Sermorelin 5mg

$43.00

SKU: SERMO Category:

Description

  • Product Overview

Sermorelin is a high-quality research peptide supplied by Pepmania exclusively for laboratory and scientific research purposes. Each batch is manufactured under strict quality standards and undergoes comprehensive testing to help ensure consistency, purity, and reliability for qualified research applications (In-Vitro use only).

None of the products offered by Pepmania have been evaluated or approved by the U.S. Food and Drug administration (FDA) for medical, therapeutic, diagnostic, or consumptive use.

  • Product information

Product Name: Sermorelin

Quantity: 5mg

Appearance: lyophilized powder

Purity: ≥99% (HPLC)

CAS Number: 86168-78-7

  • Product Description

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), which stimulates the pituitary gland to produce and release more natural growth hormone.

This product is intended to provide researchers with a consistent, high-quality material suitable for laboratory protocols and investigational studies. It is supplied as a lyophilized powder to support stability during storage and handling.

  • Quality Standards

Every batch is produced with an emphasis on quality and consistency. Our products undergo rigorous quality control procedures and analytical testing to verify identity and purity before release.

Important Notice

  • FOR RESEARCH USE ONLY (RUO).

All compounds provided by Pepmania are intended solely for laboratory research conducted by qualified professionals.

Not for human or veterinary use. Not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Not intended for consumption.

By purchasing this product, the buyer acknowledges & accepts, responsibility for ensuring compliance with all applicable laws, regulations, and institutional guidelines regarding the handling and use of research materials.

Reviews

There are no reviews yet.

Be the first to review “Sermorelin 5mg”

Your email address will not be published. Required fields are marked *